Nasal Mometasone for Chronic Sinusitis

No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if using mometasone in nasal rinses affects cortisol levels in individuals with chronic rhinosinusitis, a common sinus condition. Mometasone may alleviate sinus symptoms by reducing inflammation, but researchers want to ensure it doesn't excessively lower cortisol, which could lead to fatigue and low blood pressure. Participants will be divided into groups receiving different doses of mometasone to identify the most effective and safe dosage. Ideal candidates are those with chronic rhinosinusitis who have undergone sinus surgery and are not currently using systemic steroids. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants a chance to contribute to early-stage medical discoveries.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you've used systemic corticosteroids in the past month or are taking medications that affect the HPA axis (a system that controls stress response and other body processes).

Is there any evidence suggesting that nasal mometasone rinse is likely to be safe for humans?

Research has shown that using mometasone as a nasal rinse is safe for short-term use in people with chronic rhinosinusitis (CRS). One study found that it does not affect cortisol levels, a hormone that helps manage stress, indicating that mometasone is well-tolerated as a nasal rinse.

Mometasone is already used in nasal sprays for allergies, supporting its safety for treating nasal issues. Although using mometasone in nasal rinses is a newer approach with less data, its established use in sprays offers some reassurance about its safety.

This trial will test different doses of mometasone (1mg, 2mg, or 4mg). Currently in the early stages, the trial focuses mainly on safety. Understanding how the body reacts to the treatment and identifying any possible side effects is crucial.12345

Why do researchers think this study treatment might be promising?

Researchers are excited about the nasal mometasone rinse because it offers a new way to deliver medication directly to the nasal passages for conditions like chronic sinusitis. Unlike traditional corticosteroid nasal sprays, this treatment uses a high-volume irrigation method, potentially enhancing the drug's effectiveness by ensuring more extensive coverage of the nasal and sinus cavities. Additionally, by experimenting with varying dosages (1mg, 2mg, and 4mg), researchers aim to identify the optimal dose that maximizes benefits while minimizing systemic cortisol suppression, a common concern with corticosteroid use. This innovative approach could lead to more effective and safer treatment options for patients suffering from sinus issues.

What evidence suggests that this trial's treatments could be effective for chronic rhinosinusitis?

Research shows that mometasone nasal rinses can ease symptoms of chronic rhinosinusitis, a condition causing long-term sinus swelling. Studies have found that large amounts of mometasone rinses work better than regular nasal sprays, especially for those who have had sinus surgery. One study showed that patients using mometasone rinses felt much better than those who did not. However, researchers continue to gather evidence and investigate the best doses and long-term effects. Mometasone reduces swelling in the nasal passages, relieving congestion and other sinus problems.26789

Who Is on the Research Team?

BT

Bobby Tajudeen, MD

Principal Investigator

Rush University Medical Center

Are You a Good Fit for This Trial?

Inclusion Criteria

Age 18+
Diagnosis of Chronic Rhinosinusitis, with or without nasal polyposis
History of prior endosopic sinus surgery
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive nasal mometasone irrigations in varying dosages for 12 weeks

12 weeks
Daily self-administration

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
1 visit (in-person) for blood draw

What Are the Treatments Tested in This Trial?

Interventions

  • Nasal Mometasone Rinse
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Mometasone 4mgExperimental Treatment1 Intervention
Group II: Mometasone 2mgExperimental Treatment1 Intervention
Group III: Mometasone 1mgExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+

Advanced Rx

Industry Sponsor

Trials
1
Recruited
20+

Published Research Related to This Trial

Mometasone furoate nasal spray is a potent treatment for allergic rhinitis and nasal polyposis that has negligible systemic exposure, minimizing the risk of significant side effects compared to oral corticosteroids.
Clinical trials involving around 4,500 patients show that mometasone furoate does not suppress the hypothalamus-pituitary-adrenal axis or inhibit growth in children, confirming its safety and tolerability profile.
Mometasone furoate nasal spray: a review of safety and systemic effects.Zitt, M., Kosoglou, T., Hubbell, J.[2022]

Citations

A Randomized Clinical Trial to Evaluate Mometasone ...Our study suggests that patients who perform mometasone lavage do better in a clinically meaningful way, but our results are not definitive and further studies ...
Effectiveness of Mometasone Nasal Irrigation for Chronic ...The aim of this study is to evaluate the effectiveness of mometasone furoate large-volume, low-pressure nasal irrigation for surgery-naive CRS patients.
High volume nasal irrigations with steroids for chronic ...High-volume irrigations demonstrated superior efficacy in symptom improvement for CRS and AR compared to nasal sprays, particularly post-surgery ...
Efficacy of Mometasone Furoate Nasal Irrigation for ...In a recent double-blinded, placebo-controlled randomized clinical trial (RCT), Harvey et al demonstrated that MF nasal irrigation was superior ...
Effectiveness of Intranasal Mometasone Furoate vs Saline ...Both nasal sprays resulted in resolution of symptoms in approximately 40% of participants. Meaning Results suggest that in primary care, first- ...
SAFETY DATA SHEETConsult product packaging insert for additional health and safety information on dosage and potential side effects from use of this product.
NASONEX® (mometasone furoate monohydrate) Nasal Spray ...The safety and effectiveness of NASONEX Nasal Spray 50 mcg for allergic rhinitis in children 12 years of age and older have been established. [see Adverse ...
Mometasone (nasal route) - Side effects & dosageMometasone nasal spray is used to treat and prevent the symptoms (eg, stuffy or runny nose, itching, sneezing) of seasonal (short-term) and perennial (year- ...
0872 Apo-Mometasone Furoate Nasal Spray_This Safety Data Sheet has been provided to inform workers of the safety, health and environmental information associated with this product.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security